Abstract
Objective: To determine the pharmacokinetics (PK) and detect changes in cardiac uptake of relative to rested subjects. The heart was visualized in early whole body scintigraphic images, but overall there were no apparent differences from images reported for rested volunteers. Minimal uptake of radiotracer in myocardium and skeletal muscle was consistent with uptake in non-stressed muscle. Conclusion: The PK and whole-body scintigrams for 
Introduction
Nuclear cardiology assesses myocardial viability and establishes a prognosis for cardiac patients [1] [2] [3] , using a range of radiotracers to observe myocardial perfusion and bioenergetics [4, 5] . An alternative imaging approach is to detect pathological, oxygen deficient (hypoxic) myocardial tissue using oxygen-sensitive radiotracers. Radiolabeled azomycins (2- [6, 7] . In theory, these radiotracers concentrate in hypoxic myocardium that has intracellular oxygen partial pressures below about 3 mm Hg (<25 % of normal), and would therefore be useful for assessing myocardial damage. [ Its efficacy as a marker of clinical hypoxia in peripheral vascular disease of diabetic origin [12] , blunt brain trauma [13] and rheumatoid joints [14] , and its clinical pharmacokinetics (PK) and radiation dosimetry in healthy volunteers [15, 16] have been reviewed [17] .
The first step in determining the suitability of [ There is no reported evidence of dose-dependency in [ 123 I]IAZA PK and hypoxia imaging [15, 17] . However, due to variability in individual mass doses of IAZA (Table 1) administered to subjects in the current study (0.57 mg to 1.18 mg, mean of 0.85 mg) and the reference study in rested volunteers, the PK parameters of interest for comparison between the two studies were limited to distribution half-life (t1/2α) and elimination half-life (t1/2β), as determined using compartmental methods, and steady-state volume of distribution (Vss) and total body clearance (CLTB), determined using NCA. 
Results
All three subjects who were enrolled in the study completed the protocol with no apparent adverse events. Demographic and dosing information are presented in Table 1 . ] in all subjects, as was the case with rested volunteers [15] . The individual and mean (± SD) compartmental (t1/2α, t1/2β), and noncompartmental (Vss and CLTB) PK parameters of interest from the cardiac-stressed volunteers in this study are presented in Table 2 , along with comparative historical data for the 6 healthy volunteers dosed under resting conditions [15] . Imaging: The myocardium and skeletal muscles were only visible in the initial whole body and SPECT images, but not on the later images in this study (Fig. 3) . The early, intermediate and late post-dosing whole-body images were consistent with those reported for rested volunteers [16] . On the earliest images, the organs with the highest radioactivity accumulation were the bladder, liver and the kidneys. could not be captured, the whole-body images obtained from exercising volunteers were consistent with those reported for rested volunteers [16] .
The myocardium and the skeletal muscles were visible on the initial whole-body and SPECT images of subjects undergoing exercise; however, all of the whole-body images (early, intermediate and late) were consistent with whole-body images in rested subjects [16] . These results indicate that myocardial radioactivity observed in the early images is most likely attributable to blood pool radioactivity in the heart and in highly perfused cardiac muscle, and not to any stress-induced hypoxia-related retention. This absence of active stressinduced uptake indicates that [ images may be indicative of a minor route of elimination via biliary excretion of radioactivity into the gut. Quantitatively, the amount of radioactivity in the large intestine represented only approximately 5% of the administered dose. Nevertheless, this small amount constitutes a significant relative contribution to the whole-body radioactivity in the late image, given that, as determined from renal excretion of total radioactivity in the 6 healthy volunteers dosed at rest on the prior study [15] , 92% of decay-adjusted total radioactivity was eliminated renally within 28 hours post-dose. However, only approximately 15.5 % of that radioactivity was attributed to intact [ [21] . For the exercise study, the radioactivity in the thyroid gland was considered irreversibly bound and eliminated with the 13.2 h decay half-life of the isotope. Since iodine incorporation into the thyroid gland takes place with a 6 -8 h half-life, it may be possible to further decrease the radiation dose to the thyroid by administering Lugol's solution earlier in the protocol [20, 21] .
The concentration-time plot of total radioactivity following [ 123 I]IAZA administration exhibits a bi-exponential decline (Fig. 1) , and therefore only two compartments were discernible. However, gamma camera scintigraphic images of the whole body delineate several physiological regions with elevated radioactivity, including liver, kidney and thyroid.
Radiopharmaceutical imaging is therefore a natural element of physiologically based pharmacokinetic (PBPK) modelling. PBPK can be used to assess the exposure in a target organ after dosing, taking into account organ-specific absorption, metabolism and disposition rates in that organ [22] ; it does not rely heavily on plasma or serum PK to elucidate all of the physiological compartments. In the current imaging work, attempts to discern whether these regions are separate compartments of a multicompartmental pharmacokinetic model for 
